Fig. 5: The TAT-tagged L5URcore peptide impacts on Ras-signaling.
From: Identification of an H-Ras nanocluster disrupting peptide
a–h Immunoblot analysis of lysates from Hs 578 T (a, e), T24 (b, f), MIA PaCa-2 (c, g), and HEK (d, h) cells after EGF-stimulation and treatment with L5URcore-derived peptides with and without TAT-tag or control compound, trametinib (Tra), for 2 h; n = 3–8.
